Our regular "Word on the Street" column provides the most entertaining and thought-provoking quotes that the BioWorld Today/BioWorld Insight staff select every week. These insights and opinions are drawn from a variety of sources: during the course of interviews with biotech executives, from industry reports provided by analysts, webcasts, and some that are gleaned at conferences that we attend. Read More
Human growth hormone (hGH) is a $3.5 billion industry, but it's plagued by a major issue: All of the current versions of hGH (somatropin) – Novo Nordisk's Norditropin, Eli Lilly and Co.'s Humatrope, Roche AG unit Genentech Inc.'s Nutropin-AQ, Merck Serono's Saizen, Teva Pharmaceutical Industries Ltd.'s Tev-tropin, LG Life Science Ltd.'s Valtropin and Omnitrope, sold by Novartis AG's generic group Sandoz – have to be injected daily. Read More
